본문 바로가기

Temporal changes in tongue color during immune checkpoint inhibitor therapy in patients with non-small-cell lung cancer: a prospective observational study using digital tongue diagnosis

문서 유형
연구출판물 · 학술지 논문
등재
ESCIScopus
저널 순위
JCR Q1Scopus Q3
저널
Oncology Reviews19 · 2025
피인용
Scopus 2
FWCI (Scopus)
0.27
JCR IF
JCR 2024 5.2
ISSN
1970-5557

저자

  1. Cho, Eunbyul제1저자Department of Diagnostics, College of Korean Medicine, Wonkwang University, Iksan, Republic of Korea
  2. Choi, WoosuDigital Health Research Division, Korea Institute of Oriental Medicine, Daejeon, Republic of Korea
  3. Lim, Jun HyeokDivision of Pulmonology, Department of Internal Medicine, Inha University Hospital, Inha University College of Medicine, Incheon, Republic of Korea
  4. Son, Ji WoongDivision of Pulmonology, Department of Internal Medicine, Konyang University Hospital, Daejeon, Republic of Korea
  5. Jang, Seung HunDivision of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Gyeonggi, Anyang, Republic of Korea
  6. Lee, Seung HyeunDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kyung Hee University Hospital, Kyung Hee University College of Medicine, Seoul, Republic of Korea
  7. Choi, Jong GwonDepartment of Oncology- Hematology, Konyang University Hospital, Daejeon, Republic of Korea
  8. Oh, In-JaeDepartment of Internal Medicine, Chonnam National University Medical School and Hwasun Hospital, Jeonnam, Republic of Korea
  9. Jang, Tae-WonDepartment of Internal Medicine, Kosin University Gospel Hospital, Busan, Republic of Korea
  10. 윤성훈Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea
  11. Kim, Seung JoonDepartment of Internal Medicine, Seoul St. Mary’s Hospital, Postech-Catholic University Biomedical Engineering Institute, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
  12. Choi, Chang-MinDepartment of Pulmonary and Critical Care Medicine, Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
  13. Lee, Sung YongDivision of Pulmonary, Allergy, and Critical Care Medicine, Korea University Guro Hospital, Seoul, Republic of Korea
  14. Ko, Mi MiKM Science Research Division, Korea Institute of Oriental Medicine, Daejeon, Republic of Korea
  15. Jeong, Mi-Kyung교신저자KM Convergence Research Division, Korea Institute of Oriental Medicine, Daejeon, Republic of Korea

초록

Background: Tongue diagnosis (TD), a key component of traditional East Asian medicine, employs a unique pattern-based diagnostic system. Digital TD enables quantitative assessment of tongue characteristics, like body and coating color, enhancing objectivity and reproducibility. While abnormal tongue features (including dark red, bluish, or pale appearance) have been documented in patients with cancer, the relationship between longitudinal changes in tongue characteristics and immune checkpoint inhibitor (ICI) treatment response or survival outcomes in non-small-cell lung cancer (NSCLC) remains underexplored. This multicenter, prospective, observational study investigated whether longitudinal tongue changes differ by ICI response and predict survival in patients with NSCLC. Methods: We enrolled patients with stage IIIB, IIIC, or IV NSCLC scheduled to receive second-line or subsequent pembrolizumab or atezolizumab following first-line platinum-based therapy failure. Digital tongue images were collected every 9 weeks from baseline to week 45. Linear mixed models evaluated temporal parameter changes and compared responders (durable clinical benefits ≥6 months) versus nonresponders. Multivariate Cox models adjusted for sex and age assessed tongue lightness changes as a prognostic value for progression-free survival (PFS) and overall survival (OS). Survival distributions were compared using Kaplan–Meier curves. Results: Of 170 enrolled participants, 140 were included in the analysis. Early in treatment, tongue lightness decreased in the body, fur, root, and center areas in both responders and nonresponders; however, the darkening was more pronounced in nonresponders, with significant visit-by-response interaction effects. In multivariate Cox analysis, lightness changes of the tongue body were significantly associated with PFS (hazard ratio [HR] = 0.93; 95% confidence interval [CI], 0.88–0.99; p = 0.019) and showed a trend for OS (HR = 0.93; 95% CI, 0.86–1.00; p = 0.062). Lightness changes of the tongue center were also significantly associated with PFS (HR = 0.95; 95% CI, 0.90–0.99; p = 0.027). Kaplan–Meier analysis confirmed that patients with a greater decrease in tongue body lightness had significantly shorter OS (p = 0.049). Conclusion: Digital TD diagnosis, particularly monitoring tongue lightness changes, may provide a valuable noninvasive prognostic tool for patients with NSCLC undergoing ICI therapy. It offers information for both PFS and OS, potentially complementing current biomarkers for cancer immunotherapy.

키워드

digital tongue imageimmunotherapylung cancerprognosistongue diagnosis

식별자

Scopus EID
2-s2.0-105025685137